Assessment of anti-psychotic drugs.
D014150:Antipsychotic Agents / Q000009:adverse effects / Q000378:metabolism / Q000627:therapeutic use*; D001480:Basal Ganglia Diseases / Q000139:chemically induced; D002908:Chronic Disease; D002986:Clinical Trials as Topic; D004353:Drug Evaluation, Preclinical; D006801:Humans; D010302:Parkinson Disease, Secondary / Q000139:chemically induced; D010974:Platelet Aggregation; D011569:Psychiatric Status Rating Scales; D011618:Psychotic Disorders / Q000175:diagnosis / Q000188:drug therapy; D012559:Schizophrenia / Q000188:drug therapy
D014150:Antipsychotic Agents